Skip to content
Home/Companies/HealthTech/RECOVID Solutions

RECOVID Solutions

HealthTech·Spain·Exited 2022·Held 2yr
Entry
2020
Hold
2yr
Exit
2022

Who owns RECOVID Solutions?

RECOVID Solutions was owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage) from 2020 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-09

Columbus Venture Partners
Investor
Columbus Venture Partners
Columbus Life Science Fund II · 2019 · Life Sciences VC

Key facts

HQSpain
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Columbus Life Science Fund II

Other portfolio companies in the same fund.

Minoryx Therapeutics
Minoryx Therapeutics
Active
BiotechSpain· 2022
NeRRe Therapeutics
Active
BiotechUnited Kingdom· 2021
Highlight Therapeutics
Highlight Therapeutics
Active
BiotechSpain· 2020
Sanifit Therapeutics
Exited 2021
BiotechSpain· 2019
to
Viralgen Commercial
Viralgen Commercial
Exited 2021
BiotechSpain· 2019
to
Radioterapia de Protones
Exited 2024
HealthcareSpain· 2017
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track RECOVID Solutions

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on RECOVID Solutions.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue